About Oxford Cardiovascular Science
Researchers across Oxford are working together at the forefront of cardiovascular science, with the overall goal of translating discoveries from the laboratory though to clinical practice. Our researchers will apply new cross cutting technologies to develop cardiovascular imaging and phenotyping, drug development, cardiac computer modelling and stem cell & gene therapy.
We have outstanding experience in conducting clinical trials and epidemiological studies as well as state-of-the-art basic science and clinical research facilities. We are particularly proud of our ability to bring together molecular, epidemiological and physiological research to understand cardiac and vascular disease right from the molecular level all the way up to the wider population.
The British Heart Foundation is a key sponsor of cardiovascular research in Oxford and their two research centres offer scientists across the city fantastic opportunities for research & training, supporting the current and next generation of leaders in Cardiovascular Science.
30 September 2022
Dr Qiang Zhang, BHF CRE Intermediate Transition Fellow, writes about how artificial intelligence is being used to advance cardiovascular imaging
5 September 2022
RDM researchers tested the method in COVID-19 patients, to find that the results predicted in-hospital mortality.
BHF CRE Director Professor Hugh Watkins wins £30 million research award to cure killer heart diseases
29 July 2022
The British Heart Foundation award aims to help researchers rewrite DNA, in “defining moment” for cardiovascular medicine.